Aureus Licenses AurSCOPE® GPCR to Euroscreen
News Oct 07, 2005
Aureus Pharma has announced that Euroscreen, SA has become a customer of its AurSCOPE GPCR knowledge database.
AurSCOPE GPCR is designed to provide researchers rapid access to quantitative biological activity data mined from the scientific journals and patents for all known GPCR's, a major class of membrane proteins.
Euroscreen will use Aureus Pharma's technology in conjunction with their in-house technology to identify GPCR drug candidates.
“By integrating the Aureus GPCR knowledge database with Euroscreen's research platform, our scientists will be able to rapidly prioritize candidates in lead generation and optimization programs,” said Dr. Francois Roman, Vice President R & D for Euroscreen.
“The information contained within the database will also help us in the design of our chemical libraries for our screening campaigns,” said Dr. Frederic Ooms, Head of Chemistry for Euroscreen.
“As Euroscreen is a world leader in GPCR research, we are pleased they have adopted our AurSCOPE GPCR knowledge base,” said Dr. Andre Michel, CEO of Aureus Pharma.
“AurSCOPE GPCR with its high quality biological and chemical information will complement Euroscreen's technology resulting in an overall acceleration of the discovery process.”
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Targeting a Leaky Protein that Causes ParalysisNews
A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018